ImmunityBio (IBRX) Profit After Tax Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.05% |
| Dec 31, 2025 | -14.03% |
| Sep 30, 2025 | -0.33% |
| Jun 30, 2025 | -12.47% |
| Mar 31, 2025 | -28.48% |
| Dec 31, 2024 | -30.46% |
| Sep 30, 2024 | -40.64% |
| Jun 30, 2024 | -51.83% |
| Mar 31, 2024 | -49.63% |
| Dec 31, 2023 | -68.19% |
| Sep 30, 2023 | -32.24% |
| Jun 30, 2023 | -37.88% |
| Mar 31, 2023 | -33.48% |
| Dec 31, 2022 | -34.45% |
| Sep 30, 2022 | -35.91% |
| Jun 30, 2022 | -32.24% |
| Mar 31, 2022 | -33.25% |
| Dec 31, 2021 | -30.45% |
| Sep 30, 2021 | -22.40% |
| Jun 30, 2021 | -21.33% |
| Mar 31, 2021 | -21.28% |
| Dec 31, 2020 | -3.68% |
| Sep 30, 2020 | -7.40% |
| Jun 30, 2020 | 17.04% |
| Mar 31, 2020 | -2.43% |
| Dec 31, 2019 | -41.52% |
| Sep 30, 2019 | -76.18% |
| Jun 30, 2019 | -63.61% |
| Mar 31, 2019 | -75.02% |